| Date23.12.2016 |
TitleVifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance |
Download
Vifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance
|
| Date23.12.2016 |
TitleVifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance to include CCX140 to treat renal diseases |
Download
Vifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance to include CCX140 to treat renal diseases
|
| Date09.12.2016 |
TitleSwisscom Health to take over Galenica practice information system |
Download
Swisscom Health to take over Galenica practice information system
|
| Date07.12.2016 |
TitleEFFECT-HF demonstrates a significantly beneficial effect of Ferinject® on exercise capacity among patients with chronic heart failure and iron deficiency – confirms findings of previous studies |
Download
EFFECT-HF demonstrates a significantly beneficial effect of Ferinject® on exercise capacity among patients with chronic heart failure and iron deficiency – confirms findings of previous studies
|
| Date28.11.2016 |
TitleFDA Approves Supplemental New Drug Application for Veltassa® Removing Boxed Warning Regarding Drug-Drug Interactions |
Download
FDA Approves Supplemental New Drug Application for Veltassa® Removing Boxed Warning Regarding Drug-Drug Interactions
|
| Date24.11.2016 |
TitleVifor Pharma leads initiatives to raise awareness of Iron Deficiency – 2nd Global Iron Deficiency Day on November 26, 2016 |
Download
Vifor Pharma leads initiatives to raise awareness of Iron Deficiency – 2nd Global Iron Deficiency Day on November 26, 2016
|
| Date25.10.2016 |
TitleSwissmedic approves ALOXI® for use in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Children in Switzerland |
Download
Swissmedic approves ALOXI® for use in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Children in Switzerland
|
| Date06.10.2016 |
TitleNew management at Vifor Pharma and new Galenica Group CFO designated |
Download
New management at Vifor Pharma and new Galenica Group CFO designated
|
| Date02.09.2016 |
TitleGalenica completes acquisition of Relypsa |
Download
Galenica completes acquisition of Relypsa
|
| Date01.09.2016 |
TitleGalenica announces Expiration of Cash Tender Offer for Relypsa |
Download
Galenica announces Expiration of Cash Tender Offer for Relypsa
|
| Date09.08.2016 |
TitleGalenica Group half year results 2016 |
Download
Galenica Group half year results 2016
|
| Date04.08.2016 |
TitleGalenica commences Tender Offer for Relypsa |
Download
Galenica commences Tender Offer for Relypsa
|
| Date21.07.2016 |
TitleGalenica to acquire Relypsa to strengthen its Business unit Vifor Pharma |
Download
Galenica to acquire Relypsa to strengthen its Business unit Vifor Pharma
|
| Date24.05.2016 |
TitleVifor Pharma to license commercialisation rights to Pfizer’s proposed biosimilar, Retacrit™, in the field of nephrology in the US |
Download
Vifor Pharma to license commercialisation rights to Pfizer’s proposed biosimilar, Retacrit™, in the field of nephrology in the US
|
| Date24.05.2016 |
TitleVifor Pharma strengthens company management – division of Galenica to take place once the new management is in place |
Download
Vifor Pharma strengthens company management – division of Galenica to take place once the new management is in place
|
| Date23.05.2016 |
TitleESC guidelines strongly recommend Ferinject® as a treatment for iron deficiency in systolic heart failure patients |
Download
ESC guidelines strongly recommend Ferinject® as a treatment for iron deficiency in systolic heart failure patients
|
| Date20.05.2016 |
TitleThe Galenica Group plans to take over SD wholesaler Pharmapool |
Download
The Galenica Group plans to take over SD wholesaler Pharmapool
|
| Date11.05.2016 |
TitleChange to the shareholder structure of the Galenica Group |
Download
Change to the shareholder structure of the Galenica Group
|
| Date10.05.2016 |
TitleVifor Pharma appoints Colin Bond as Chief Financial Officer |
Download
Vifor Pharma appoints Colin Bond as Chief Financial Officer
|
| Date10.05.2016 |
TitleVifor Pharma licenses marketing rights to CCX168 in certain territories |
Download
Vifor Pharma licenses marketing rights to CCX168 in certain territories
|
| Date09.05.2016 |
TitleVifor Fresenius Medical Care Renal Pharma acquires marketing rights to RAYALDEE® |
Download
Vifor Fresenius Medical Care Renal Pharma acquires marketing rights to RAYALDEE®
|
| Date28.04.2016 |
Title2016 Annual General Meeting of Galenica Ltd. |
Download
2016 Annual General Meeting of Galenica Ltd.
|
| Date25.04.2016 |
TitlePatiromer submitted to EMA to seek approval in the EU |
Download
Patiromer submitted to EMA to seek approval in the EU
|
| Date15.03.2016 |
TitleResults of the Galenica Group 2015 |
Download
Results of the Galenica Group 2015
|
| Date21.01.2016 |
Title2015 sales of the Galenica Group |
Download
2015 sales of the Galenica Group
|